A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis
Clinical trial NCT03626012 · COMPLETED
Trial details
- NCT number
- NCT03626012
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2021-11-17
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.